Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Takeuchi, Kazuhiko ^a   Renic, Marija ^a   Bohman, Quinn C ^a   Harder, David R ^a   Miyata, Noriyuki ^b   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Medicinal Research Laboratories   (Japan)

Author keywords

20 hydroxyeicosatetraenoic acid; Cerebral injury; Subarachnoid hemorrhage

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN VASOSPASM; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ANIMALS; ANTERIOR CEREBRAL ARTERY; ARACHIDONIC ACID; BASILAR ARTERY; CEREBROVASCULAR CIRCULATION; CISTERNA MAGNA; FORMAMIDES; HYDROXYEICOSATETRAENOIC ACIDS; INJECTIONS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE CEREBRAL ARTERY; MORPHOLINES; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 27144490317     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00556.2005     Document Type: Article

References (59)

1. Aihara Y, Jahromi BS, Yassari R, Nikitina E, Agbaje-Williams M, and Macdonald RL. Molecular profile of vascular ion channels after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 24: 75-83, 2004.
2. Alonso-Galicia M, Maier KG, Greene AS, Cowley AW Jr, and Roman RJ. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283: R60-R68, 2002.
3. Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins AL III, and Vallabhajosyula P. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 42: 352-360, 1998.
4. Broderick JP, Brott TG, Duldner JE, Tomsick T, and Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25: 1342-1347, 1994.
5. 1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke 34: 1269-1275, 2003.
6. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol Ther 66: 259-284, 1995.
7. D'Avella D, Germano A, Santoro G, Costa G, Zuccarello M, Caputi AP, Hayes RL, and Tomasello F. Effect of experimental subarachnoid hemorrhage on CSF eicosanoids in the rat. J Neurotrauma 1: 121-129, 1990.
8. Dahly-Vernon AJ, Sharma M, McCarthy ET, Savin VJ, Ledbetter SR, and Roman RJ. Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats. Hypertension 45: 643-648, 2005.
9. Delgado TJ, Brismar J, and Svendgaard NA. Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16: 595-602, 1985.
10. Dorsch NW. Cerebral arterial spasm-a clinical review. Br J Neurosurg 9: 403-412, 1995.
11. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, Nithipatikom K, Campbell WB, and Harder DR. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 87: 60-65, 2000.
12. 2+ current. J Physiol 507: 771-781, 1998.
13. Gules I, Satoh M, Clower BR, Nanda A, and Zhang JH. Comparison of three rat models of cerebral vasospasm. Am J Physiol Heart Circ Physiol 283: H2551-H2559, 2002.
14. Harder DR. Increased sensitivity of cat cerebral arteries to serotonin upon elevation of transmural pressure. Pflügers Arch 411: 698-700, 1988.
15. Harder DR, Dernbach P, and Waters A. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest 80: 875-880, 1987.
16. Hiroshima Y, Endo S, Kato R, and Takaku A. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880. J Neurosurg 84: 826-830, 1996.
17. Hop JW, Rinkel GJ, Algra A, and van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 28: 660-664, 1997.
18. Kehl F, Cambj-Sapunar L, Maier KG, Miyata N, Kametani S, Okamoto H, Hudetz AG, Schulte ML, Zagorac D, Harder DR, and Roman RJ. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol 282: H1556-H1565, 2002.
19. Kim DE, Suh YS, Lee MS, Kim KY, Lee JH, Lee HS, Hong KW, and Kim CD. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 33: 2687-2691, 2002.
20. Kusaka G, Kimura H, Kusaka I, Perkins E, Nanda A, and Zhang JH. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 99: 383-390, 2003.
21. Kuwayama A, Zervas NT, Shintani A, and Pickren KS. Papaverine hydrochloride and experimental hemorrhagic cerebral arterial spasm. Stroke 3: 27-33, 1972.
22. Laher I and Zhang JH. Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab 21: 887-906, 2001.
23. Lan C, Das D, Wloskowicz A, and Vollrath B. Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C. Am J Physiol Heart Circ Physiol 286: H165-H173, 2004.
24. Lange A, Gebremedhin D, Narayanan J, and Harder D. 20- Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J Biol Chem 272: 27345-27352, 1997.
25. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, and Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 12: 126-136, 1993.
26. Macdonald RL, Weir BK, Marton LS, Zhang ZD, Sajdak M, Johns LM, Kowalczuk A, and Borsody M. Role of adenosine 5′-triphosphate in vasospasm after subarachnoid hemorrhage: human investigations. Neurosurgery 48: 854-862, 2001.
27. Matz P, Turner C, Weinstein PR, Massa SM, Panter SS, and Sharp FR. Heme-oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res 713: 211-222, 1996.
28. Meguro T, Clower BR, Carpenter R, Parent AD, and Zhang JH. Improved rat model for cerebral vasospasm studies. Neurol Res 23: 761-766, 2001.
29. Megyesi JF, Vollrath B, Cook DA, and Findlay JM. In vivo animal models of cerebral vasospasm: a review. Neurosurgery 46: 448-460, 2000.
30. Meyer CH, Lowe D, Meyer M, Richardson PL, and Neil-Dwyer G. Progressive change in cerebral blood flow during the first three weeks after subarachnoid hemorrhage. Neurosurgery 12: 58-76, 1983.
31. Miyata N, Seki T, Tanaka Y, Omura T, Taniguchi K, Doi M, Bandou K, Kametani S, Sato M, Okuyama S, Cambj-Sapunar L, Harder DR, and Roman RJ. Beneficial effects of a new 20-HETE synthesis inhibitor, TS-011, on hemorrhagic and ischemic stroke. J Pharmacol Exp Ther 2005.
32. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, and Malik KU. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 95: 12701-12706, 1998.
33. Muthalif MM, Benter IF, Khandekar Z, Gaber L, Estes A, Malik S, Parmentier JH, Manne V, and Malik KU. Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension. Hypertension 35: 457-463, 2000.
34. Muthalif MM, Karzoun NA, Gaber L, Khandekar Z, Benter IF, Saeed AE, Parmentier JH, Estes A, and Malik KU. Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 36: 604-609, 2000.
35. Muthalif MM, Uddin MR, Fatima S, Parmentier J, Khandekar Z, and Malik KU. Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells. Prostaglandins 65: 33-43, 2001.
36. Ca channel. Br J Pharmacol 137: 1362-1370, 2002.
37. Obara K, Nishizawa S, Koide M, Nozawa K, Mitate A, Ishikawa T, and Nakayama K. Interactive role of protein kinase C-delta with rhokinase in the development of cerebral vasospasm in a canine two-hemorrhage model. J Vasc Res 42: 67-76, 2005.
38. Pickard JD, Walker V, Brandt L, Zygmunt S, and Smythe J. Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemorrhage on CSF eicosanoids. Acta Neurochir (Wien) 129: 152-157, 1994.
39. Poloyac SM, Reynolds RB, Yonas H, and Kerr ME. Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage. J Neurosci Methods 144: 257-263, 2005.
40. Randriamboavonjy V, Busse R, and Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 41: 801-806, 2003.
41. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
42. Saida A, Ito H, Shibuya T, and Watanabe Y. Time-course alterations of monoamine levels and cerebral blood flow in brain regions after subarachnoid hemorrhage in rats. Brain Res Bull 43: 69-80, 1997.
43. Sakamoto M, Takaki E, Yamashita K, Watanabe K, Tabuchi S, Watanabe T, and Satoh K. Nonenzymatic derived lipid peroxide, 8-iso-PGF2 alpha, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model. Neurol Res 24: 301-306, 2002.
44. Seifert V, Loffler BM, Zimmermann M, Roux S, and Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82: 55-62, 1995.
45. Sewer MB, Koop DR, and Morgan ET. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450. Drug Metab Dispos 24: 401-407, 1996.
46. Sobey CG and Faraci FM. Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 25: 867-876, 1998.
47. Sobey CG, Heistad DD, and Faraci FM. Effect of subarachnoid hemorrhage on dilatation of rat basilar artery in vivo. Am J Physiol Heart Circ Physiol 271: H126-H132, 1996.
48. Sobey CG and Quan L. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 277: H1718-H1724, 1999.
49. + channel activity and vascular tone in renal arterioles. Circ Res 83: 1069-1079, 1998.
50. Sun CW, Falck JR, Harder DR, and Roman RJ. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33: 414-418, 1999.
51. Suzuki H, Kanamaru K, Tsunoda H, Inada H, Kuroki M, Sun H, Waga S, and Tanaka T. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 104: 59-66, 1999.
52. Varsos VG, Liszczak TM, Han DH, Kistler JP, Vielina J, Black PM, Heros RC, and Zervas NT. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model. J Neurosurg 58: 11-17, 1983.
53. Weir B. The pathophysiology of cerebral vasospasm. Br J Neurosurg 9: 375-390, 1995.
54. Weir B, Grace M, Hansen J, and Rothberg C. Time course of vasospasm in man. J Neurosurg 48: 173-178, 1978.
55. Wickman G, Lan C, and Vollrath B. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm. Circ Res 92: 809-816, 2003.
56. Widenka DC, Medele RJ, Stummer W, Bise K, and Steiger HJ. Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J Neurosurg 90: 1098-1104, 1999.
57. Yamaguchi M, Zhou C, Nanda A, and Zhang JH. Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke 35: 1750-1755, 2004.
58. Yin W, Tibbs R, Tang J, Badr A, and Zhang J. Haemoglobin and ATP levels in CSF from a dog model of vasospasm. J Clin Neurosci 9: 425-428, 2002.
59. Yu M, Cambj-Sapunar L, Kehl F, Maier KG, Takeuchi K, Miyata N, Ishimoto T, Reddy LM, Falck JR, Gebremedhin D, Harder DR, and Roman RJ. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. Eur J Pharmacol 486: 297-306, 2004.